• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高c-Met表达是结直肠癌的负性预后标志物:一项荟萃分析。

High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis.

作者信息

Gao HeLi, Guan Mei, Sun Zhao, Bai ChunMei

机构信息

Department of Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China,

出版信息

Tumour Biol. 2015 Feb;36(2):515-20. doi: 10.1007/s13277-014-2659-5. Epub 2015 Jan 31.

DOI:10.1007/s13277-014-2659-5
PMID:25636446
Abstract

Recent studies have shown that c-Met is an important signal in the development of colorectal cancer, but the prognostic value of c-Met remains unclear. We aimed to analyze the prognostic effect of c-Met in colorectal cancer through a systematic review and meta-analysis. Through database searches, we identified six articles describing how c-Met status affects colorectal cancer prognosis. A meta-analysis was performed to investigate the relationship between the hazard ratio and survival. The available outcome data from six articles were examined. A meta-analysis of the HR and the 95% confidence interval (CI) indicated a significantly poor overall survival and disease-free survival in patients with high expression levels of c-Met. The subgroup analysis showed that the prognostic effect of the c-Met level was similar in different methods and was not associated with disease stages. High c-Met expression levels could predict a poor prognosis in colorectal cancer patients. The c-Met status could be used to evaluate the prognosis in clinical patients.

摘要

近期研究表明,c-Met是结直肠癌发生发展过程中的一个重要信号,但c-Met的预后价值仍不明确。我们旨在通过系统评价和荟萃分析来分析c-Met在结直肠癌中的预后作用。通过数据库检索,我们识别出6篇描述c-Met状态如何影响结直肠癌预后的文章。进行荟萃分析以研究风险比与生存率之间的关系。对这6篇文章中可得的结局数据进行了审查。对风险比(HR)和95%置信区间(CI)的荟萃分析表明,c-Met高表达水平的患者总生存期和无病生存期显著较差。亚组分析显示,不同方法中c-Met水平的预后作用相似,且与疾病分期无关。c-Met高表达水平可预测结直肠癌患者预后不良。c-Met状态可用于评估临床患者的预后。

相似文献

1
High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis.高c-Met表达是结直肠癌的负性预后标志物:一项荟萃分析。
Tumour Biol. 2015 Feb;36(2):515-20. doi: 10.1007/s13277-014-2659-5. Epub 2015 Jan 31.
2
C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.C-Met作为胃癌的预后标志物:一项系统评价和荟萃分析。
PLoS One. 2013 Nov 4;8(11):e79137. doi: 10.1371/journal.pone.0079137. eCollection 2013.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.用于转移性结直肠癌的表皮生长因子受体(EGFR)抑制剂
Cochrane Database Syst Rev. 2017 Jun 27;6(6):CD007047. doi: 10.1002/14651858.CD007047.pub2.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.无细胞游离 DNA 在转移性结直肠癌中的应用:系统评价和荟萃分析。
Oncologist. 2017 Sep;22(9):1049-1055. doi: 10.1634/theoncologist.2016-0178. Epub 2017 Aug 4.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.通过 RT-PCR 检测非转移性结直肠癌循环肿瘤细胞的预后和临床病理意义:荟萃分析和系统评价。
BMC Cancer. 2017 Nov 7;17(1):725. doi: 10.1186/s12885-017-3704-8.
10
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.

引用本文的文献

1
Impact of Neoadjuvant Treatment on Target Expression in Rectal Cancer for Near-Infrared Tumor Imaging.新辅助治疗对直肠癌近红外肿瘤成像中靶点表达的影响。
Cancers (Basel). 2025 Jun 12;17(12):1958. doi: 10.3390/cancers17121958.
2
Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review.探索结直肠癌中的预测性和预后生物标志物:综述
Cancers (Basel). 2024 Aug 8;16(16):2796. doi: 10.3390/cancers16162796.
3
MET Oncogene Targeting for Cancer Immunotherapy.MET 癌基因靶向治疗用于癌症免疫治疗。

本文引用的文献

1
C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.C-Met作为胃癌的预后标志物:一项系统评价和荟萃分析。
PLoS One. 2013 Nov 4;8(11):e79137. doi: 10.1371/journal.pone.0079137. eCollection 2013.
2
c-MET overexpression as a prognostic biomarker in colorectal adenocarcinoma.c-MET过表达作为结直肠癌的一种预后生物标志物
Gulf J Oncolog. 2013 Jul;1(14):28-34.
3
Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.
Int J Mol Sci. 2024 Jun 1;25(11):6109. doi: 10.3390/ijms25116109.
4
Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.癌症的靶向治疗:从正在进行的临床试验到 FDA 批准的药物。
Int J Mol Sci. 2023 Sep 3;24(17):13618. doi: 10.3390/ijms241713618.
5
Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer.局部晚期结肠癌治疗的生物标志物的全面综述。
Cells. 2022 Nov 23;11(23):3744. doi: 10.3390/cells11233744.
6
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.在不符合抗 MET 靶向治疗条件的 MET 过表达肿瘤中,CAR-T 免疫疗法的疗效。
J Exp Clin Cancer Res. 2022 Oct 21;41(1):309. doi: 10.1186/s13046-022-02479-y.
7
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers.卡博替尼联合或不联合帕尼单抗治疗 RAS 野生型转移性结直肠癌:MET 扩增对临床结局和循环生物标志物的影响。
Cancer Chemother Pharmacol. 2022 Mar;89(3):413-422. doi: 10.1007/s00280-022-04404-8. Epub 2022 Feb 16.
8
Personalizing first-line treatment in advanced colorectal cancer: Present status and future perspectives.晚期结直肠癌一线治疗的个体化:现状与未来展望。
J Clin Transl Res. 2021 Nov 29;7(6):771-785. eCollection 2021 Dec 28.
9
HGF/MET Axis Induces Tumor Secretion of Tenascin-C and Promotes Stromal Rewiring in Pancreatic Cancer.肝细胞生长因子/间质-上皮转化因子轴诱导胰腺癌中肌腱蛋白-C的肿瘤分泌并促进基质重塑
Cancers (Basel). 2021 Jul 14;13(14):3519. doi: 10.3390/cancers13143519.
10
Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review).结直肠癌的研究新动向:失调的信号通路(综述)。
Int J Mol Med. 2021 Mar;47(3). doi: 10.3892/ijmm.2021.4847. Epub 2021 Jan 7.
血管内皮生长因子受体1、3和小窝蛋白-1与结直肠癌的侵袭性和预后相关——与表皮生长因子受体、CD44v6、粘着斑激酶和c-Met的相关性
Tumour Biol. 2013 Aug;34(4):2109-17. doi: 10.1007/s13277-013-0776-1. Epub 2013 Apr 12.
4
Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer.关注ficlatuzumab在非小细胞肺癌治疗中的潜在作用。
Biologics. 2013;7:61-8. doi: 10.2147/BTT.S28908. Epub 2013 Mar 3.
5
Multivariate analysis of molecular indicators for postoperative liver metastasis in colorectal cancer cases.结直肠癌病例术后肝转移分子指标的多变量分析
Asian Pac J Cancer Prev. 2012;13(8):3967-71. doi: 10.7314/apjcp.2012.13.8.3967.
6
FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.在结直肠癌的参数中,FAK、CD44v6、c-Met 和 EGFR:肿瘤进展、转移、患者生存和受体串扰。
Int J Colorectal Dis. 2013 Jan;28(1):9-18. doi: 10.1007/s00384-012-1520-9. Epub 2012 Jun 26.
7
Expression of the hepatocyte growth factor and c-Met in colon cancer: correlation with clinicopathological features and overall survival.肝细胞生长因子和c-Met在结肠癌中的表达:与临床病理特征及总生存期的相关性
Tumori. 2012 Jan-Feb;98(1):105-12. doi: 10.1177/030089161209800115.
8
Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation.天然维甲素A通过抑制Akt和c-MET激活诱导葡萄膜黑色素瘤细胞凋亡。
Tumour Biol. 2012 Aug;33(4):1179-89. doi: 10.1007/s13277-012-0363-x. Epub 2012 Apr 5.
9
Targeting MET in cancer: rationale and progress.靶向 MET 治疗癌症:原理与进展。
Nat Rev Cancer. 2012 Jan 24;12(2):89-103. doi: 10.1038/nrc3205.
10
Coexpression of activated c-Met and death receptor 5 predicts better survival in colorectal carcinoma.活化的 c-Met 和死亡受体 5 的共表达可预测结直肠癌患者的生存更好。
Am J Pathol. 2011 Dec;179(6):3032-44. doi: 10.1016/j.ajpath.2011.08.007. Epub 2011 Oct 5.